Related Experiment Video
Updated: Jul 4, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
In vitro/in vivo comparisons in pulmonary drug delivery
Stephen P Newman1, Hak-Kim Chan
1steve.newman@physics.org
In vitro aerodynamic particle size distribution (APSD) data can predict lung deposition for inhaled drugs. Lung deposition closely matches the aerosol dose smaller than 3 micrometers, improving inhaler device comparisons.
Area of Science:
- Pharmaceutical Sciences
- Respiratory Drug Delivery
- Inhalation Technology
Background:
- Establishing in vitro-in vivo correlations for inhaled drugs is crucial for product development.
- Aerodynamic particle size distribution (APSD) is a key in vitro metric for predicting lung deposition and clinical effects.
- Current methods for measuring APSD may not fully represent the in vivo conditions of drug delivery.
Purpose of the Study:
- To investigate the relationship between in vitro APSD and in vivo lung deposition for inhaled drug products.
- To evaluate the predictive power of different APSD metrics for lung deposition across various inhaler devices.
- To identify potential improvements in in vitro methods for better correlation with clinical outcomes.
Main Methods:
- Comparison of APSD data from cascade impaction with lung deposition data from gamma scintigraphy studies.
- Analysis of whole-lung deposition in relation to fine particle fraction (FPF) and particle size distributions.
- Evaluation of different FPF definitions (e.g., <5.8 µm, <6.8 µm) and their correlation with deposition.
Main Results:
- Whole-lung deposition showed a significant correlation with FPF across different inhaler devices.
- FPF metrics systematically overestimated lung deposition for most inhalers.
- Lung deposition demonstrated closer numerical equivalence to the percentage of aerosol dose <3 µm.
Conclusions:
- Correlations between APSD and whole-lung deposition support the use of APSD for comparing inhaler devices.
- Measuring APSD using methods that mimic clinical use, such as simulated upper airway anatomy, may improve in vitro-in vivo agreement.
- Further research is needed to establish unambiguous links between APSD and clinical response for inhaled drugs.
Related Concept Videos
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Drug Product Performance: In Vitro–In Vivo Correlation
Equivalence: In Vitro and In Vivo Bioequivalence
Modified-Release Drug Delivery Systems: Bioavailability
Bioequivalence studies: Biowaivers

